top of page

PANC-1 Xenograft Model

Rincon Bio offers efficacy studies using the PANC-1 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Pancreatic
Derivation:
Pancreatic duct of epithelioid carcinoma of a 56yo male
Mutations:
KRAS, TP53
NCI60:
No
Weeks from stratification to termination (average):
3

PANC-1 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the PANC-1 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page